Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

5.1K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

1.1K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.1K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

2.3K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.3K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

7.8K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
7.8K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

1.3K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.3K
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

7.3K
The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

X-inactive specific transcript (XIST) can determine sex differences in cardiovascular drug responses: focus on RNA therapeutics.

Frontiers in pharmacology·2026
Same author

Neighborhood Disadvantage and Risk of Hospitalization in a Home-Based Cardiac Rehabilitation Program After Acute Myocardial Infarction: A Retrospective Cohort Study.

Journal of the American Heart Association·2025
Same author

Technology enabled home-based cardiac rehabilitation among women with cardiovascular disease: A longitudinal cohort study.

International journal of cardiology. Cardiovascular risk and prevention·2023
Same author

Distinct hypoxia-induced translational profiles of embryonic and adult-derived macrophages.

iScience·2023
Same author

Guidelines on the use of sex and gender in cardiovascular research.

American journal of physiology. Heart and circulatory physiology·2023
Same author

Effects of androgen excess and body mass index on endothelial function in women with polycystic ovary syndrome.

Journal of applied physiology (Bethesda, Md. : 1985)·2023
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Apr 4, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

13.0K

Menopause and the Heart.

Chileshe Nkonde-Price1, Jeffrey R Bender2

  • 1Penn Heart and Vascular Center for Women's Cardiovascular Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Endocrinology and Metabolism Clinics of North America
|August 29, 2015
PubMed
Summary
This summary is machine-generated.

Postmenopausal hormone replacement therapy

Keywords:
Cardiovascular riskHeartHormone replacement therapyMenopause

More Related Videos

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

16.4K
Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

2.7K

Related Experiment Videos

Last Updated: Apr 4, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

13.0K
A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

16.4K
Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

2.7K

Area of Science:

  • Cardiovascular Health
  • Women's Health
  • Endocrinology

Background:

  • Cardiovascular disease (CVD) is a primary cause of mortality in postmenopausal women.
  • The role of hormone replacement therapy (HRT) in postmenopausal cardiovascular risk remains a significant debate in women's health.
  • Conflicting findings exist between observational studies and randomized clinical trials regarding HRT and CVD.

Purpose of the Study:

  • To critically evaluate the impact of postmenopausal hormone replacement therapy on cardiovascular risk.
  • To address unresolved questions concerning the optimal timing for initiating hormone therapy.
  • To outline current cardiovascular concerns, precautions, and recommendations for HRT use.

Main Methods:

  • Review and synthesis of existing literature, including observational studies and randomized clinical trials.
  • Analysis of discordant findings between different study designs.
  • Discussion of ongoing and future clinical trials investigating HRT and cardiovascular outcomes.

Main Results:

  • Observational studies and randomized clinical trials have yielded conflicting results on HRT's cardiovascular effects.
  • The timing of HRT initiation appears critical in influencing cardiovascular outcomes.
  • Ongoing research aims to clarify these discrepancies and provide definitive guidance.

Conclusions:

  • The relationship between postmenopausal hormone therapy and cardiovascular risk is complex and context-dependent.
  • Careful consideration of individual risk factors and timing of initiation is crucial.
  • Current recommendations emphasize caution and individualized treatment strategies for HRT.